A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
Titel:
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
Auteur:
von Krempelhuber, Alfred Vollmar, Jens Pokorny, Rolf Rapp, Petra Wulff, Niels Petzold, Barbara Handley, Amanda Mateo, Lyn Siersbol, Henriette Kollaritsch, Herwig Chaplin, Paul